Increased expression of glucagon-like peptide-1 receptors in psoriasis plaques

Experimental Dermatology

Volumn 22, Issue 2, 2013, Pages 150-152

  Faurschou, Annesofie ^a   Pedersen, Jens ^b   Gyldenløve, Mette ^a   Poulsen, Steen S ^b   Holst, Jens J ^b   Thyssen, Jacob P ^a   Zachariae, Claus ^a   Vilsbøll, Tina ^a   Skov, Lone ^a   Knop, Filip K ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Glucagon like peptide 1; Psoriasis; Skin

Indexed keywords

GAMMA INTERFERON; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

BLOOD SAMPLING; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INCUBATION TIME; KERATINOCYTE; LETTER; PROTEIN EXPRESSION; PSORIASIS VULGARIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SKIN BIOPSY;

ADULT; BIOPSY; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; KERATINOCYTES; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, GLUCAGON; SKIN; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84873160243     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12081     Document Type: Letter

References (22)

1. Hare K J, Knop F K. Vitam Horm 2010: 84: 389-413.
2. Astrup A, Rössner S, Van Gaal L et al. Lancet 2009: 374: 1606-1616.
3. Hogan A E, Tobin A M, Ahern T et al. Diabetologia 2011: 54: 2745-2754.
4. Faurschou A, Knop F K, Thyssen J P et al. Acta Diabetol 2011. Early online.
5. Buysschaert M, Tennstedt D, Preumont V. Diabete Metab 2012: 38: 86-88.
6. Ahern T, Tobin A M, Corrigan M et al. J Eur Acad Dermatol Venereol 2012. Early online.
7. Faurschou A, Zachariae C, Skov L et al. Med Hypotheses 2011: 77: 1098-1101.
8. Hattori Y, Jojima T, Tomizawa A et al. Diabetologia 2010: 53: 2256-2263.
9. Kodera R, Shikata K, Kataoka H U et al. Diabetologia 2011: 54: 965-978.
10. Hadjiyanni I, Siminovitch K A, Danska J S et al. Diabetologia 2010: 53: 730-740.
11. Marx N, Burgmaier M, Heinz P et al. Cell Mol Life Sci 2010: 67: 3549-3555.
12. Kim Chung le T, Hosaka T, Yoshida M et al. Biochem Biophys Res Commun 2009: 390: 613-618.
13. Dozier K C, Cureton E L, Kwan R O et al. Peptides 2009: 30: 1735-1741.
14. List J F, He H, Habener J F. Regul Pept 2006: 134: 149-157.
15. Strange P, Skov L, Baadsgaard O. J Invest Dermatol 1994: 102: 150-154.
16. Bucinskaite V, Tolessa T, Pedersen J et al. Neurogastroenterol Motil 2009: 21: 978-e78.
17. Drucker D Understanding incretin hormone action and the treatment of diabetes. 44th Claude Bernard Lecture. EASD 2012. Available at: http://www.easdvirtualmeeting.org/resources/2118#, slide 42-44.
18. Hadjiyanni I, Baggio L L, Poussier P et al. Endocrinology 2008: 149: 1338-1349.
19. Zhang J, Tokui Y, Yamagata K et al. Diabetologia 2007: 50: 1900-1909.
20. Gerdes S, Osadtschy S, Rostami-Yazdi M et al. Exp Dermatol 2012: 21: 43-47.
21. Abdel Hay R M, Rashed L A. Exp Dermatol 2011: 20: 715-719.
22. Gerdes S, Rostami-Yazdi M, Mrowietz U. Exp Dermatol 2011: 20: 81-87.